Interventions targeting IL8 and the pro‐inflammatory tumor milieu may find a new use in normalizing breast cancer desmoplasia, as exemplified by dexamethasone, which was recently shown to increase stromal and vascular normalization in murine breast cancer models.[60]. The gene discussed is CXCL8; the disease is neoplasm.